Ramonville St Agne, France

David Shire

This inventor holds 1 USPTO granted patent. Top assignee: Sanofi. Active years: 1995.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: David Shire - Innovator in Protein Expression Technology

Introduction

David Shire is a notable inventor based in Ramonville St Agne, France. He has made significant contributions to the field of biotechnology, particularly in the area of protein expression in yeast. His innovative work has implications for various applications in medicine and research.

Latest Patents

David Shire holds a patent for an artificial promoter designed for the expression of proteins, specifically urate oxidase, in yeast. This invention enhances the efficiency of protein production, which is crucial for various biotechnological applications. The patent showcases his expertise and commitment to advancing scientific knowledge.

Career Highlights

David Shire is currently employed at Sanofi, a leading global healthcare company. His role at Sanofi allows him to work on cutting-edge projects that aim to improve health outcomes through innovative solutions. His experience and knowledge in biotechnology have positioned him as a valuable asset to the company.

Collaborations

Throughout his career, David has collaborated with esteemed colleagues such as Pascal Leplatois and Gerard Loison. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

David Shire's contributions to the field of biotechnology, particularly through his patent for an artificial promoter, highlight his role as an innovator. His work at Sanofi and collaborations with other experts further emphasize his commitment to advancing scientific research and technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…